|
⚲
|
| Keyboard |
| Kairos Venture Partners II LP
✚
|
|
|---|---|
| CIK # | 0001696711 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001696711] | |
| 4 | [0001696711] | |
| D | [0001696711] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kairos Venture Partners II LP | |
| Actuate Therapeutics Inc | |
| Thomson Todd S | |
| Kairos Venture Opportunities I LP | |
| Kairos SPV Fund LLC | |
| Kairos-Actuate SPV LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2026-01-05 | Sell | 280,000 | $5.80 | 1,624,000 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 146,870 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 230,597 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 138,889 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 726,163 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 1,058,318 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 69,445 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 132,908 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 24,138 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 49,984 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Option exercise | 28,464 | $5.27 | 150,005 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Sell | 18,750 | $8.00 | 150,000 |
|
Actuate Therapeutics Inc ACTU
Series B-4 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 230,597 | ||
|
Actuate Therapeutics Inc ACTU
Series B-4 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 132,908 | ||
|
Actuate Therapeutics Inc ACTU
Series C Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 49,984 | ||
|
Actuate Therapeutics Inc ACTU
Series C Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 24,138 | ||
|
Actuate Therapeutics Inc ACTU
Series B-3 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 138,889 | ||
|
Actuate Therapeutics Inc ACTU
Series B-3 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 146,870 | ||
|
Actuate Therapeutics Inc ACTU
Series B-3 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 69,445 | ||
|
Actuate Therapeutics Inc ACTU
Series B-2 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 726,163 | ||
| showing 20 of 23 most recent transactions | |||||